| scholarly article | Q13442814 |
| P2093 | author name string | Andrew R Hoffman | |
| An H Nguyen | |||
| Thanh H Vu | |||
| P2860 | cites work | Parental imprinting of the mouse H19 gene | Q22122365 |
| Interchromosomal associations between alternatively expressed loci | Q22122480 | ||
| CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to Igf2 | Q24295238 | ||
| CTCF: master weaver of the genome | Q24621388 | ||
| Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene | Q28145754 | ||
| CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus | Q28145756 | ||
| Looping and interaction between hypersensitive sites in the active beta-globin locus | Q28198196 | ||
| Capturing chromosome conformation | Q28201750 | ||
| Chromosome Conformation Capture Carbon Copy (5C): a massively parallel solution for mapping interactions between genomic elements | Q28262061 | ||
| Disruption of imprinting caused by deletion of the H19 gene region in mice | Q28287765 | ||
| Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome | Q28592236 | ||
| Physical linkage of two mammalian imprinted genes, H19 and insulin-like growth factor 2 | Q31158518 | ||
| Chromatin conformation signatures of cellular differentiation | Q33431476 | ||
| Mapping networks of physical interactions between genomic elements using 5C technology | Q34578862 | ||
| Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer | Q34620502 | ||
| Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming | Q35130964 | ||
| Imprinting of human H19: allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching | Q35194604 | ||
| Analysis of the H19ICR insulator | Q35856849 | ||
| Coregulated human globin genes are frequently in spatial proximity when active | Q36116796 | ||
| Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk | Q36693375 | ||
| A complex deoxyribonucleic acid looping configuration associated with the silencing of the maternal Igf2 allele | Q36710170 | ||
| Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer | Q36835706 | ||
| Three-dimensional conformation at the H19/Igf2 locus supports a model of enhancer tracking | Q36876294 | ||
| CTCF regulates allelic expression of Igf2 by orchestrating a promoter-polycomb repressive complex 2 intrachromosomal loop | Q36959918 | ||
| Glucocorticoid receptor activation of the Ciz1-Lcn2 locus by long range interactions | Q37112229 | ||
| The long noncoding RNA Kcnq1ot1 organises a lineage-specific nuclear domain for epigenetic gene silencing | Q37201459 | ||
| Increased expression of the insulin-like growth factor-II gene in Wilms' tumor is not dependent on loss of genomic imprinting or loss of heterozygosity | Q38351907 | ||
| Transient homologous chromosome pairing marks the onset of X inactivation | Q40327289 | ||
| Global loss of imprinting leads to widespread tumorigenesis in adult mice | Q40361864 | ||
| Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer | Q40766020 | ||
| Visualization of looping involving the immunoglobulin heavy-chain locus in developing B cells | Q40974584 | ||
| Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region | Q41726237 | ||
| Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops | Q42632085 | ||
| Disruption of an imprinted gene cluster by a targeted chromosomal translocation in mice | Q42658164 | ||
| CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1. | Q43651581 | ||
| A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis | Q46050836 | ||
| Promoter-specific imprinting of the human insulin-like growth factor-II gene | Q46095293 | ||
| Mouse/human sequence divergence in a region with a paternal-specific methylation imprint at the human H19 locus | Q48061527 | ||
| Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human. | Q48096674 | ||
| Transient colocalization of X-inactivation centres accompanies the initiation of X inactivation. | Q51822086 | ||
| Altered gene expression and methylation of the human chromosome 11 imprinted region in small for gestational age (SGA) placentae. | Q51954217 | ||
| Relaxation of imprinted genes in human cancer. | Q52545355 | ||
| Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. | Q53472225 | ||
| Parental imprinting of the mouse insulin-like growth factor II gene. | Q55052428 | ||
| Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour | Q59088779 | ||
| IGF-II serum levels are normal in children with Silver-Russell syndrome who frequently carry epimutations at the IGF2 locus. | Q64970681 | ||
| IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome | Q70765937 | ||
| Parental genomic imprinting of the human IGF2 gene | Q72222239 | ||
| Loss of IGF2 imprinting: a potential marker of colorectal cancer risk | Q73128690 | ||
| Imprinting status of 11p15 genes in Beckwith-Wiedemann syndrome patients with CDKN1C mutations | Q74051048 | ||
| Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site | Q74114381 | ||
| Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability | Q77534962 | ||
| Epigenetic regulation of Ifng expression | Q80501241 | ||
| Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice | Q81441297 | ||
| Molecular biology. Managing associations between different chromosomes | Q83154060 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 901-919 | |
| P577 | publication date | 2009-12-16 | |
| P1433 | published in | Human Molecular Genetics | Q2720965 |
| P1476 | title | Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells | |
| P478 | volume | 19 |
| Q57029709 | A Loss of Epigenetic Control Can Promote Cell Death through Reversing the Balance of Pathways in a Signaling Network |
| Q34383700 | Analysis of long-range chromatin interactions using Chromosome Conformation Capture |
| Q38089897 | Blood-based peptide, genetic, and epigenetic biomarkers for diagnosing gastrointestinal cancers |
| Q33798311 | CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator of IGF2 imprinting in tumors |
| Q27024282 | Cancer control and prevention by nutrition and epigenetic approaches |
| Q38038646 | Chromatin structure, epigenetic mechanisms and long-range interactions in the human insulin locus. |
| Q91792543 | DNA methylation in human diseases |
| Q35020435 | Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells |
| Q57199288 | Extensive investigation of the IGF2/H19 imprinting control region reveals novel OCT4/SOX2 binding site defects associated with specific methylation patterns in Beckwith-Wiedemann syndrome |
| Q37811902 | Gene insulation. Part II: natural strategies in vertebrates |
| Q37961799 | Genetic and epigenetic dysregulation of imprinted genes in the brain |
| Q35375811 | Genome-wide approaches for cancer gene discovery. |
| Q31137734 | Genomic interaction profiles in breast cancer reveal altered chromatin architecture |
| Q29248130 | IGF2-derived miR-483 mediated oncofunction by suppressing DLC-1 and associated with colorectal cancer |
| Q30630876 | Identifying multi-locus chromatin contacts in human cells using tethered multiple 3C |
| Q42373538 | Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4. |
| Q50982222 | Increased In Vitro Osteopotential in SHED Associated with Higher IGF2 Expression When Compared with hASCs |
| Q39166609 | Induced DNA demethylation can reshape chromatin topology at the IGF2-H19 locus. |
| Q37301123 | Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer |
| Q34918219 | Interruption of intrachromosomal looping by CCCTC binding factor decoy proteins abrogates genomic imprinting of human insulin-like growth factor II. |
| Q36813932 | Loss of imprinting of IGF2 and the epigenetic progenitor model of cancer |
| Q37588289 | Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells |
| Q83449447 | Mapping of INS promoter interactions reveals its role in long-range regulation of SYT8 transcription |
| Q37831991 | Molecular mechanisms of genomic imprinting and clinical implications for cancer |
| Q37890322 | Multi-biomarker pattern for tumor identification and prognosis |
| Q95300522 | Profound alterations of the chromatin architecture at chromosome 11p15.5 in cells from Beckwith-Wiedemann and Silver-Russell syndromes patients |
| Q36559183 | Promoter cross-talk via a shared enhancer explains paternally biased expression of Nctc1 at the Igf2/H19/Nctc1 imprinted locus. |
| Q39107608 | Promoter histone H3K27 methylation in the control of IGF2 imprinting in human tumor cell lines |
| Q38832417 | Restoration of IGF2 imprinting by polycomb repressive complex 2 docking factor SUZ12 in colon cancer cells |
| Q36155532 | Role of nuclear architecture in epigenetic alterations in cancer |
| Q37988364 | Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation |
| Q38002967 | Targeting epigenetic mediators of gene expression in thoracic malignancies. |
| Q36931989 | The human imprintome: regulatory mechanisms, methods of ascertainment, and roles in disease susceptibility |
Search more.